JIM CRAMERGlaxoSmithKline, CenturyLink, Health Catalyst: 'Mad Money' Lightning RoundBy Scott RuttAug 27, 2019 8:15 PM EDT
JIM CRAMERBuilding Economic Strength: Cramer's 'Mad Money' RecapBy Scott RuttAug 20, 2019 8:33 PM EDT
EARNINGSGlaxoSmithKline Beats Q2 Profit Estimate, Sees Stronger 2019 Despite Advair LossBy Martin BaccardaxJul 24, 2019 8:24 AM EDT
INVESTINGPfizer Could Be a Healthy Option in This Volatile MarketBy Stephen GuilfoyleJan 2, 2019 9:25 AM EST
MARKETSStocks Hit New Lows After Early Rally as Fed Hikes Key RateBy TheStreet StaffDec 19, 2018 4:36 PM EST
MARKETSFed, Micron, Glaxo and Pfizer, FedEx and Facebook - 5 Things You Must KnowBy Joseph WoelfelDec 19, 2018 8:30 AM EST
STOCKSGlaxoSmithKline, Pfizer Form Consumer Healthcare Group with $13 Billion in SalesBy Martin BaccardaxDec 19, 2018 4:03 AM EST
JIM CRAMERAbbott, Glaxo, Casella and More: 'Mad Money' Lightning RoundBy Scott RuttDec 8, 2018 1:56 PM EST
MARKETSDow Ends Up Sharply; Stocks Rally on Easing Trade TensionsBy TheStreet StaffDec 3, 2018 4:11 PM EST
STOCKSGlaxoSmithKline Makes $5.1 Billion Play for Cancer Drug Specialist TesaroBy Martin BaccardaxDec 3, 2018 10:02 AM EST
MARKETSDrug Stocks Climb as Investors Digest Midterm Election ResultsBy Armie Margaret LeeNov 7, 2018 12:22 PM EST
MARKETSGSK Shares Climb as Board Is Said to Mull Breakup of Pharma GiantBy Armie Margaret LeeJul 20, 2018 4:52 PM EDT
MARKETSElliott Tackles AC Milan After Chinese Investors Falter; Pfizer Eyes Reorg--ICYMIBy Michael D. BrownJul 11, 2018 8:00 PM EDT
MARKETSPfizer to reorganize itself into 3 business unitsBy Armie Margaret LeeJul 11, 2018 9:56 AM EDT
POLITICSCreates Act Clears Committee Vote, Could Ease Way for Generic DrugmakersBy Bill MeagherJun 15, 2018 1:18 PM EDT
MARKETSMylan Slumps in After-Hours Trading on Generic Advair UpdateBy Armie Margaret LeeJun 13, 2018 6:05 PM EDT
POLITICSTrump Administration Ups Dose Of Shame As TV Drug Ad Policy Idea Moves ForwardBy Bill MeagherMay 23, 2018 6:32 PM EDT
STOCKS20 Top Stocks From Around the World With an Average 25% Upside PotentialBy Brian SozziMay 16, 2018 6:48 AM EDT
MARKETSWhat to Expect from Allergan, Aetna, Merck and Pfizer's Earnings Next WeekBy Armie Margaret LeeApr 27, 2018 4:52 PM EDT
JIM CRAMERWalgreens, Arena Pharma, Dominion Energy: 'Mad Money' Lightning RoundBy Scott RuttApr 27, 2018 6:48 AM EDT
